Overview

Drug-Drug Interaction of Rifampicin and Cyclosporine on Methotrexate Pharmacokinetics in Healthy Subjects

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2026-04-14

Target enrollment:

Participant gender:

Summary

This study will evaluate how methotrexate is processed in the body when given with low doses of rifampicin or cyclosporine. These drugs may affect how methotrexate is absorbed and cleared, which could change its safety and effectiveness. Healthy volunteers will receive methotrexate with either rifampicin or cyclosporine, and blood samples will be collected to measure drug levels. The findings may help identify possible drug interactions and improve the safe use of methotrexate.

Phase:

PHASE1

Details

Lead Sponsor:

Seoul National University Bundang Hospital

Treatments:

Cyclosporine
Methotrexate
Rifampin